Authors:
Dupuis, S
Dargemont, C
Fieschi, C
Thomassin, N
Rosenzweig, S
Harris, J
Holland, SM
Schreiber, RD
Casanova, JL
Citation: S. Dupuis et al., Impairment od mycobacterial but not viral immunity by a germline human STAT1 mutation, SCIENCE, 293(5528), 2001, pp. 300-303
Authors:
Fieschi, C
Dupuis, S
Picard, C
Smith, CIE
Holland, SM
Casanova, JL
Citation: C. Fieschi et al., High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency, PEDIATRICS, 107(4), 2001, pp. NIL_19-NIL_21
Authors:
Sherman, DG
Bes, A
Easton, JD
Hacke, W
Kaste, M
Polmar, SH
Zivin, JA
Fieschi, C
Miller, P
Schoenfeld, D
Street, J
Albers, G
Atkinson, R
Biller, J
Bruno, A
Carpenter, D
Clark, W
DeGraba, T
Driscoll, P
Ellis, J
Greenlee, R
Hess, D
Horowitz, DR
Davenport, J
Hsu, C
Starkman, S
Madden, K
Pettigrew, C
Rosenbaum, D
Schim, J
Tietjen, G
Mansbach, H
Edwards, K
Webb, R
Crisostomo, E
Wilterdink, J
Rothrock, J
Zweifler, R
Dexter, J
Horowitz, S
Futrell, N
Alter, M
Schneider, D
Ferbert, A
Hacke, W
Prange, H
Wiersbitzky, M
Buttner, T
Schwartz, A
Busse, O
Klingelhofer, J
Kaste, M
Erila, T
Sivenius, J
Sotaniemi, K
Liukkonen, J
Hedman, C
Muuronen, A
Rissanen, A
Bes, A
Feve, JR
Mahagne, MH
Rancurel, G
Trouillas, P
Weber, M
Thomassen, L
Johnsen, HJ
Kjallman, L
Petersson, J
Ferrari, G
Lagi, A
Mamoli, A
Re, G
Citation: Dg. Sherman et al., Use of anti-ICAM-1 therapy in ischemic stroke - Results of the Enlimomab Acute Stroke Trial, NEUROLOGY, 57(8), 2001, pp. 1428-1434
Authors:
Bastianello, S
Paolillo, A
Giugni, E
Giuliani, S
Evangelisti, G
Luccichenti, G
Angeloni, U
Colonnese, C
Salvetti, M
Gasperini, C
Pozzilli, C
Fieschi, C
Citation: S. Bastianello et al., MRI of spinal cord in MS, J NEUROVIRO, 6, 2000, pp. S130-S133
Authors:
Dupuis, S
Doffinger, R
Picard, C
Fieschi, C
Altare, F
Jouanguy, E
Abel, L
Casanova, JL
Citation: S. Dupuis et al., Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion, IMMUNOL REV, 178, 2000, pp. 129-137
Authors:
De Castro, S
Cartoni, D
Fiorelli, M
Rasura, M
Anzini, A
Zanette, EM
Beccia, M
Colonnese, C
Fedele, F
Fieschi, C
Pandian, NG
Citation: S. De Castro et al., Morphological and functional characteristics of patent foramen ovale and their embolic implications, STROKE, 31(10), 2000, pp. 2407-2413
Authors:
Gollob, JA
Veenstra, KG
Jyonouchi, H
Kelly, AM
Ferrieri, P
Panka, DJ
Altare, F
Fieschi, C
Casanova, JL
Frank, DA
Mier, JW
Citation: Ja. Gollob et al., Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infections, J IMMUNOL, 165(7), 2000, pp. 4120-4126
Authors:
Jouanguy, E
Dupuis, S
Pallier, A
Doffinger, R
Fondaneche, MC
Fieschi, C
Lamhamedi-Cherradi, S
Altare, F
Emile, JF
Lutz, P
Bordigoni, P
Cokugras, H
Akcakaya, N
Landman-Parker, J
Donnadieu, J
Camcioglu, Y
Casanova, JL
Citation: E. Jouanguy et al., In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptorsfail to bind IFN-gamma, J CLIN INV, 105(10), 2000, pp. 1429-1436
Authors:
Dode, C
Papo, T
Fieschi, C
Pecheux, C
Dion, E
Picard, F
Godeau, P
Bienvenu, J
Piette, JC
Delpech, M
Grateau, G
Citation: C. Dode et al., A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family, ARTH RHEUM, 43(7), 2000, pp. 1535-1542
Citation: J. Bogousslavsky et C. Fieschi, Recovery after Acute Stroke - Symposium to the 8th European Stroke Conference, Venice, April 7-10, 1999 - Preface, CEREB DIS, 9, 1999, pp. 1-1
Authors:
Pontieri, FE
Conti, G
Zocchi, A
Fieschi, C
Orzi, F
Citation: Fe. Pontieri et al., Metabolic mapping of the effects of WIN 55212-2 intravenous administrationin the rat, NEUROPSYCH, 21(6), 1999, pp. 773-776
Authors:
Greco, A
Minghetti, L
Sette, G
Fieschi, C
Levi, G
Citation: A. Greco et al., Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis, NEUROLOGY, 53(8), 1999, pp. 1876-1879
Authors:
Antonelli, G
Simeoni, E
Bagnato, F
Pozzilli, C
Turriziani, O
Tesoro, R
Di Marco, P
Gasperini, C
Fieschi, C
Dianzani, F
Citation: G. Antonelli et al., Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b, J NEUR SCI, 168(2), 1999, pp. 131-136